Cartilize Co. has acquired the exclusive global licensing rights for iPS-derived cartilage cells

Cartilize Co. is a spin-out of Kyoto University’s CiRA and based on technology by Noriyuki TSUMAKI to generate cartilage from autologous iPS cells. The license was granted from iPS Academia.

Cartilize Co. news release, www.cartilize.com/about.html

Most popular posts: